{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-071449","form_type":"8-K","ticker":null,"cik":"0001835416","company_name":"Moringa Acquisition Corp","filed_at":"2024-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.797940+00:00","generated_at":"2026-05-31T08:17:58.816606+00:00","sec_items":["1.01","2.01","3.01","3.02","3.03","5.01","5.02","5.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Moringa Acquisition Corp completes de-SPAC merger with Silexion; begins trading as SLXN","bullets":["Business combination closed Aug. 15, 2024; combined company renamed Silexion Therapeutics Corp, trading on Nasdaq under SLXN and SLXNW starting Aug. 16, 2024.","Redemptions: 427,297 Moringa Class A shares redeemed; 87,722 public shares remained and converted into New Pubco ordinary shares.","Post-combination: 9,768,396 ordinary shares and 5,940,000 warrants outstanding; Greenstar, L.P. purchased 200,000 shares at $10 each ($2M) in a private placement.","Directors Ruth Alon, Michael Basch, Eric Brachfeld, Craig Marshak resigned; CEO Ilan Levin and CFO Gil Maman left; Ilan Hadar appointed as director.","Moringa securities delisted from Nasdaq; public shareholders who did not redeem received shares of the combined company."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-071449","json":"https://secwatch.observer/filing/0001213900-24-071449.json","markdown":"https://secwatch.observer/filing/0001213900-24-071449.md","text":"https://secwatch.observer/filing/0001213900-24-071449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/ea0212019-8k_moringa.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:17:58.816606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0078c55c22","claim":"Eric Brachfeld departed as Director at Moringa Acquisition Corp.","evidence_excerpt":"each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"48959eeddd","claim":"Ilan Levin departed as Chief Executive Officer at Moringa Acquisition Corp.","evidence_excerpt":"Ilan Levin and Gil Maman ceased to be the Chief Executive Officer and Chief Financial Officer, respectively, of Moringa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"7af3ed2c63","claim":"Michael Basch departed as Director at Moringa Acquisition Corp.","evidence_excerpt":"each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d278243329","claim":"Ilan Hadar was appointed as Director at Moringa Acquisition Corp.","evidence_excerpt":"Ilan Hadar was appointed a director of Moringa immediately following the consummation of the Business Combination","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d8fd7ff695","claim":"Craig Marshak departed as Director at Moringa Acquisition Corp.","evidence_excerpt":"each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e5976d8c36","claim":"Gil Maman departed as Chief Financial Officer at Moringa Acquisition Corp.","evidence_excerpt":"Ilan Levin and Gil Maman ceased to be the Chief Executive Officer and Chief Financial Officer, respectively, of Moringa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"fe033eef31","claim":"Ruth Alon departed as Director at Moringa Acquisition Corp.","evidence_excerpt":"each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}